Pharmaceutical company AstraZeneca is planning to increase its total revenue by 75% and release 20 new medicines by 2030, including cancer treatments.

Plus, AstraZeneca’s Aradhana Sarin discusses margins, the Inflation Reduction Act and obesity drugs.

Aradhana Sarin, MD, who is currently Alexion’s executive vice president and CFO, will replace Marc Dunoyer as AstraZeneca’s CFO.

AstraZeneca is beginning to see momentum behind its oncology portfolio. CFO Aradhana Sarin says the work is only just beginning.

AstraZeneca has unveiled plans to become the dominant global presence in breast and lung cancer markets. Click here for my Q2 earnings release preview.

Q4 2022 NASDAQ:AZN Andy Barnett Pascal Soriot Yahoo Finance Aradhana Sarin David Fredrickson Earnings Call Transcript Show more ...